Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1996 Jun;51(6):966-73.
doi: 10.2165/00003495-199651060-00005.

Practical guidelines for the treatment of cholera

Affiliations
Review

Practical guidelines for the treatment of cholera

C Seas et al. Drugs. 1996 Jun.

Abstract

Cholera is a dramatic clinical illness that requires rapid diagnosis and aggressive therapy. Clinical signs and symptoms of mild, moderate and severe dehydration must be determined, before beginning fluid therapy. Fluid therapy has 2 phases: rehydration (first 3 to 4 hours to correct deficits) and maintenance (to match continuing losses). The route and speed of fluid administration will depend on the degree of dehydration. Patients with severe dehydration should be treated intravenously, as should those patients who do not tolerate oral rehydration solution (ORS). Ringer's lactate is the preferred intravenous solution, although normal saline may be used along with ORS. For most patients with cholera, an ORS using one of the higher sodium-containing solutions and plain water optimally provide the fluid and salt needed. Close monitoring of intake, outputs and hydration status should be performed for all patients. Antimicrobial therapy should be given to moderately and severely ill patients in order to decrease the volume of fluids lost and to shorten the period of excretion of vibrios.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Sci Am. 1991 May;264(5):50-6 - PubMed
    1. Wkly Epidemiol Rec. 1992 Aug 21;67(34):253-60 - PubMed
    1. Lancet. 1993 Aug 14;342(8868):387-90 - PubMed
    1. J Commun Dis. 1992 Mar;24(1):55-7 - PubMed
    1. Lancet. 1964 Feb 15;1(7329):355-7 - PubMed

MeSH terms

Substances

LinkOut - more resources